Fig. 3: Change of HbA1c, body fat percentage, fat mass, and fat-free mass in the open label extension study.

MM metformin during RCT and extension study, PM placebo during RCT and metformin during extension study, PP placebo during RCT and extension study, MP metformin during RCT and placebo during extension study. Dotted line represents no change